OMED
Alyeska Investment Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-534,309
| Closed | -$1.23M | – | 562 |
|
|
2018
Q2 | $1.23M | Buy |
534,309
+17,086
| +3% | +$39.5K | 0.01% | 358 |
|
|
2018
Q1 | $1.65M | Sell |
517,223
-4,660
| -0.9% | -$14.8K | 0.01% | 335 |
|
|
2017
Q4 | $2.14M | Hold |
521,883
| – | – | 0.02% | 306 |
|
|
2017
Q3 | $2.36M | Buy |
521,883
+9,320
| +2% | +$42.1K | 0.02% | 324 |
|
|
2017
Q2 | $1.71M | Sell |
512,563
-193,677
| -27% | -$645K | 0.01% | 341 |
|
|
2017
Q1 | $6.5M | Buy |
706,240
+16,986
| +2% | +$156K | 0.05% | 278 |
|
|
2016
Q4 | $5.31M | Sell |
689,254
-182,048
| -21% | -$1.4M | 0.04% | 312 |
|
|
2016
Q3 | $9.96M | Buy |
871,302
+439,572
| +102% | +$5.02M | 0.09% | 265 |
|
|
2016
Q2 | $5.32M | Buy |
431,730
+106,730
| +33% | +$1.31M | 0.05% | 294 |
|
|
2016
Q1 | $3.29M | Buy |
325,000
+165,802
| +104% | +$1.68M | 0.03% | 300 |
|
|
2015
Q4 | $3.59M | Sell |
159,198
-47,285
| -23% | -$1.07M | 0.04% | 270 |
|
|
2015
Q3 | $3.43M | Buy |
206,483
+18,898
| +10% | +$314K | 0.04% | 288 |
|
|
2015
Q2 | $4.22M | Buy |
187,585
+28,034
| +18% | +$631K | 0.05% | 272 |
|
|
2015
Q1 | $4.11M | Sell |
159,551
-93,107
| -37% | -$2.4M | 0.06% | 284 |
|
|
2014
Q4 | $5.5M | Sell |
252,658
-50,257
| -17% | -$1.09M | 0.09% | 248 |
|
|
2014
Q3 | $5.73M | Buy |
302,915
+52,481
| +21% | +$993K | 0.12% | 205 |
|
|
2014
Q2 | $5.84M | Sell |
250,434
-11,329
| -4% | -$264K | 0.13% | 193 |
|
|
2014
Q1 | $8.81M | Sell |
261,763
-17,817
| -6% | -$600K | 0.24% | 116 |
|
|
2013
Q4 | $8.25M | Buy |
279,580
+10,583
| +4% | +$312K | 0.33% | 94 |
|
|
2013
Q3 | $4.12M | Buy |
+268,997
| New | +$4.12M | 0.17% | 135 |
|